Recombinant Human C17orf37 Protein，GST

C17orf37, also known as C17orf37 gene, encodes a protein of unknown function that has garnered attention in recent years due to its potential implications in various diseases, including cancer and neurodegenerative disorders. This gene maps to chromosome 17 and is thought to play a role in cellular processes such as cell proliferation and apoptosis. Studies have indicated that alterations in C17orf37 expression may be associated with tumorigenesis, suggesting it could serve as a biomarker for certain malignancies. Furthermore, its involvement in cellular stress responses and potential interactions with key signaling pathways highlight the significance of understanding its biological role. The recombinant protein derived from C17orf37 offers a promising avenue for investigating its functional properties and elucidating its mechanisms of action. By producing and characterizing this protein, researchers aim to explore its interactions with other cellular components, which may unveil novel therapeutic targets. Additionally, the development of antibodies against C17orf37 could facilitate studies on its localization and expression patterns in various tissues, further clarifying its potential roles in health and disease. Overall, the study of C17orf37 recombinant protein represents a critical step towards delineating the biological significance of this enigmatic gene and its potential contributions to disease pathogenesis.